Newsletter subscription & archive

European Patients’ Academy on Therapeutic Innovation

13-02-2020

The project aims to train and educate patients and lay people to better and more informed engage in the medicines research and development processes. The project has developed a freely available toolbox and other assets. https://dk.eupati.eu/

The involvement of patients in R&D and product development is an important strategic component of small and large businesses and public administration. The European Patients' Academy on Therapeutic Innovaiton (EUPATI) strenghten patient engagement in medicines R&D by providing a neutral platform for certified education and a repository for educational material:

"The overall goal of EUPATI is of utmost importance to the biotech and pharma companies, as it is a unique opportunity to speed up the empowerment of patients as partners for pharmaceutical companies in R&D activities. This involvement is expected to support all steps of R&D and to make R&D more efficient and more targeted to patient needs."

See https://www.eupati.eu/efoeupati/

Patient education, see https://www.eupati.eu/

Biopeople has currently involvment in IMI2 EFOEUPATI with a broad partnership of European patient organisations and companies,

and the EIT Health EUPATI RELOAD with Bayer Pharma and European Patient's Forum (EPF).

In Danish: Den danske EUPATI platforms - EUPATI Danmarks - vision er at uddanne patienter til at deltage aktivt i medicinudvikling. See https://dk.eupati.eu/

Biopeople contact: Per Spindler

Close
What are you looking for?